Peptidyl boronic acids inhibit the degradation of presenilin-1 in presenilin-1 transfected cells

Alzheimer's Reports

Volumn 3, Issue 3, 2000, Pages 169-175

  Christie, Gary ^a,c   Hussain, Ishrut ^a   Smith, Laura ^b   Mansfield, Fiona ^b   Bresciani, Laura ^a   Davis, John B ^b   Gray, Carol W ^b   Markwell, Roger ^a   Wadsworth, Harry ^a   King, Ron ^b   McLaughlin, Mark ^b   Cooper, David G ^a   Karran, Eric ^b   Ward, Robin V ^b  

^a New Frontiers Science Park ^*  (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^c Nycomed Amersham   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 23044519882     PISSN: 14616130     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Beher D, Elle C, Underwood J étal. (1999). Proteolytic fragments of Alzheimer's Disease-associated presenilin-1 are present in synaptic organelles and growth cone membranes of rat brain. J NeurochemK, 1564-1573.
2. Christie G, Markwell RE, Gray CW etal. (1999). Alzheimer's disease: correlation of the suppression of β-amyloid peptide secretion from cultured cells with inhibition of the chymotrypsin-like activity of the proteasome. JNeurochem7Z, 195-204.
3. Craiu A, Gaczynska M, Akopian T etal. (1997) Lactacystin and clastolactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibilityt complex class I antigen presentation. J' Biol C/te/77272,13437-13445.
4. Fenteany G, Standaert RF, Lane WS et al. (1995). Inhibiton of proteasome-specific amino-terminal threonine modification by lactacystin. Science268,726-731.
5. Fraser PE, Levesque G, Yu G étal. (1998). Presenilin 1 is actively degraded by the 26S proteasome. Neurobiol'of'Aging"19, S19S21.
6. Gardner RC, Assinder SJ, Christie G étal. (2000). Characterisation of peptidyl boronic acid inhibitors of mammalian 20S and 26S proteasomes and their inhibition of proteasomes in cultured cells. JBiochem 346,447-454.
7. Goate A, Chartier-Harlin M-C, Mullan Met at. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. /Vature3A9, 704-706.
8. Goldberg A and Rock K. (1992). Proteolysis, proteasomes and antigen presentation. NatureSJ, 3344-3349.
9. Grünberg J.Walter J, LoetscherH etal. (1998). Alzheimers-disease associated presenilin-1 holoprotein and its 18-20 kDa C-terminal fragment are death substrates for proteases of the caspase family. Biochemistry?!, 2263-2270.
10. Hilt W and Wolf DH. (1996). Proteasomes: destruction as a programme. Trends Biochem Soc. 21,96-102.
11. Honda I, Yasutake K, Nihonmatsu N étal. (1999) Dual roles of the proteasome in the metabolism of presenilin 1. JNeumchemTl, 255-261.
12. KimT-W, Pettingel W, Hallmark O etal. (1997). Endoproteolytic cleavage and proteasomal degradation of presenilin 2 in transfected cells. J Biol Chem212,11006-11010.
13. Kovacs DM, Fausett HJ, Page KJ et at. (1996) Alzhemier-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nature Medicine 2,224-229.
14. Levy-Lahad E, Wasco W, Poorkaj P étal. (1995). Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269,973-977.
15. Lowe J, Stock D, Jap R étal. (1995). Crystal structure of the 20S proteasome from the archaeon T-Acidophilum at 3.4 Angstrom resolution. Sc/ence2B6,533-539.
16. Mercken M.Takahashi H, Honda T et al. (1996). Characterization of human presenilin 1 using N-terminal specific monoclonal antibodies. FEBSLettyto, 297-303.
17. Marambaud P, Ancilio K, Lopez-Perez E and Checler F. (1998a). Proteasome inhibitors prevent the degradation of familial Alzheimer's disease-linked presenilin 1 and potentiate Aβ42 recovery from human cells. MolMedb, 141-157.
18. Marambaud P, Alves da Costa C, Anclioa K and Checler F. (1998b), Alzheimer's disease-linked mutation of presenilin 2 (N1411-PS2) drastically lowers APPa secretion: Control by the proteasome. Biochemand'Biophys Res Comm252,134-138.
19. Podlisny M, Citron M, Amarante P etal. (1997). Presenilin proteins undergo heterogenous endoproteolysis between Thr291 and Ala229 and occur as stable N- and C-terminal fragments in normal and Alzheimer's disease brain. Neurobiol3,325-337.
20. Ratovitski T, Slunt HH, Thinakaran G etal. (1997). Endoproteolytic processing and stabilization of wild-type and mutant presenilin. J BiolChem272,24536-24541.
21. Sherrington R, Rogaev El, Linag Y eta!. (1995). Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Naturells, 754-760.
22. Steiner H, Capell A, Pesold B état. (1999). Expression of Alzheimer's disease-associated presenilin-1 is controlled by proteolytic degradation and complex formation. JBiol C/iem273, 3232232331.
23. Thinkaran G, Borchelt DR, Lee MK etal. (1996) Endoproteolysis of presenilin and accumulation of processed derivatives in vivo. Neuron1,181-190.
24. TomitaT, Maruyama K, SaidoT etal. (1997). The presenilin 2 mutation (N141I) linked to Alzheimer's disease (Volga German families) increase the secretion of amyloid βprotein ending at the 42nd (or 43rd) residue. PATAS94,2025-2030.
25. Ward RV, Davis JB, Gray CW etal. (1996) Presenilin-1 is processed into two major cleavage products in neuronal cell lines, NeurodegenerationS, 293-298.
26. Wolfe MS, Xia W, Ostaszewski BL etal. (1999). Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and -y-secretase activity. Nafure39B, 512-517.
27. Zhang J, Kang DE, Xia W etal. (1998). Subcellular distribution and turnover of presenilins in transfected cells. JB/o/C/>em273,1243612442.